![](/fileadmin/_processed_/csm_capsule_by_design_exvolvo-web_5315d0b612.jpg)
No more needles - Exvolvo arises with help of Verily and NLC Health
NLC Health Ventures launches a new early-stage drug delivery company. The venture builder from The Netherlands partners with Verily from which Exolvo...
![](/fileadmin/_processed_/csm_Ignate1_SLAS_19d7db8119.png)
Semarion Ltd. wins Ignite SME award at SLAS Europe
Last night, the 19,000-member Society for Laboratory Automation and Screening (SLAS) has been presenting the Ignite Award for the most...
![](/fileadmin/_processed_/csm_Nordic_Bioproducts_Group_f4678ba458.png)
Nordic Bioproducts Group opens its first production facility
Nordic Bioproduct’s commercial-scale manufacturing site is expected to create €40m in revenue in the first full operating year. In...
![](/fileadmin/_processed_/csm_Labmate-currency-2317703_1280_be218675b3.jpg)
LabGenius raises £35m to expand its antibody discovery platform
The investment brings LabGenius’ total funding to £58m. The new round was led by new investor M Ventures (Merck’s venture capital). New investors...
![](/fileadmin/_processed_/csm_drugs_pills_-web_4e35a70ff4.jpg)
Ten drug recommendations by EMA
The committee recommended end of June granting a marketing authorisation for Balversa (erdafitinib), for the treatment of adult...
![](/fileadmin/_processed_/csm_NALFD_model_7770420204.png)
DefiniGEN and Atelerix prevent freezing damage in cell models
The agreement between the British companies combines DefiniGEN’s iPSC hepatocytes (Opti-Heps) with Atelerix's hydrogel preservation technology, which...
![](/fileadmin/_processed_/csm_SFactory01_Launch_044ec847f4.png)
Solar Foods starts Factory01
Following market authorisation in Singapore two years ago, the Finnish company Solar Foods Oy and the Japanese food giant Ajinomoto Group want to...